Immediate Impact
4 standout
Citing Papers
H2AX: A key player in DNA damage response and a promising target for cancer therapy
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Works of Justin D. Lu being referenced
Abnormal dopamine receptor signaling allows selective therapeutic targeting of neoplastic progenitors in AML patients
2021
Phosphorylation state of the histone variant H2A.X controls human stem and progenitor cell fate decisions
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Justin D. Lu | 54 | 29 | 26 | 37 | 36 | 21 | 154 | |
| Stephanie K. Fabbro | 84 | 11 | 29 | 25 | 17 | 15 | 152 | |
| Karen Gibbon | 68 | 16 | 70 | 43 | 8 | 14 | 160 | |
| Yssra Soliman | 100 | 16 | 44 | 20 | 25 | 17 | 204 | |
| Collin M. Blattner | 107 | 36 | 22 | 18 | 7 | 31 | 216 | |
| Zeynep Meltem Akkurt | 76 | 20 | 46 | 30 | 31 | 210 | ||
| Caroline Kang | 39 | 47 | 12 | 66 | 2 | 23 | 205 | |
| Jennifer Clough | 6 | 54 | 30 | 19 | 16 | 19 | 224 | |
| Charlene Lam | 64 | 25 | 67 | 10 | 6 | 19 | 165 | |
| J. De Maubeuge | 55 | 11 | 24 | 46 | 19 | 172 | ||
| Miguel Alpalhão | 45 | 19 | 25 | 16 | 1 | 24 | 162 |
All Works
Login with ORCID to disown or claim papers
Loading papers...